Rocket


Overview
Financials
News + Filings





Income Statement
Cash Flow Statement

Greenwich LifeSciences, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18
   S-1S-1
Revenues  2,6061,270
            Revenue growth  105.2% 
Cost of goods sold  3,4251,690
Gross profit  -819-420
            Gross margin  -31.4%-33.0%
Selling, general and administrative   [+]819420
Other operating expenses  1,788850
EBITDA   [+]-3,418-1,682
            EBITDA margin  -131.1%-132.5%
Depreciation  44
EBITA  -3,422-1,686
            EBITA margin  -131.3%-132.8%
Amortization of intangibles  44
EBIT   [+]-3,425-1,690
            EBIT margin  -131.4%-133.0%
Pre-tax income  -3,425-1,690
Income taxes  00
            Tax rate  0.0%0.0%
Net income  -3,425-1,690
            Net margin  -131.4%-133.0%
   
Basic EPS   [+]($0.57)($3.12)
Diluted EPS   [+]($0.57)($3.12)
   
Shares outstanding (basic)   [+]6,029542
Shares outstanding (diluted)   [+]6,029542
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy